Reviewed for 2026

Using PHQ-9, GAD-7, and C-SSRS in Indian Therapy Practice (2026)

Written by Kshitij Domadia, Founder, MyKaya

Published August 7, 2026

In modern mental health care, objective measurement is no longer just a research tool—it is a clinical necessity. In India, the Mental Healthcare Act (MHCA) 2017 has catalyzed a transition toward rights-based, standardized, and evidence-supported care.

For Indian therapists, implementing standardized screeners like the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Columbia-Suicide Severity Rating Scale (C-SSRS) is essential. However, using these western-standardized tools in an Indian clinical context requires careful consideration of cultural, linguistic, and somatic differences.


The three core screeners in clinical practice

Standardized assessments provide a reliable baseline, help monitor treatment progress, and validate clinical decisions for both the practitioner and the client.

1. PHQ-9 (Patient Health Questionnaire-9)

The PHQ-9 is a 9-item tool used to screen, diagnose, and monitor the severity of depression. It is based directly on the diagnostic criteria for major depressive disorder.

  • Target: Depression severity and suicide ideation (Item 9).
  • Clinical Value: Tracks changes over time to measure treatment efficacy.

2. GAD-7 (Generalized Anxiety Disorder-7)

A 7-item self-report questionnaire designed to assess the severity of generalized anxiety disorder, panic disorder, social anxiety, and PTSD.

  • Target: Anxiety severity.
  • Clinical Value: Helps differentiate generalized anxiety from situational stress.

3. C-SSRS (Columbia-Suicide Severity Rating Scale)

The C-SSRS is the gold standard for suicide risk assessment. It evaluates the severity and immediacy of suicidal ideation and behavior.

  • Target: Suicide risk classification (Low, Moderate, High).
  • Clinical Value: Provides clear, actionable risk categories that direct safety planning.

Clinical assessment reference guide

The table below summarizes the scoring thresholds and clinical responses for each standard tool:

ScreenerScore rangeSeverity categoryStandard clinical response
PHQ-90–4MinimalPsychoeducation; monitor status.
5–9MildWatchful waiting; repeat at next visit.
10–14ModerateConsider counseling, psychotherapy, or pharmacotherapy.
15–19Moderately SeverePsychotherapy and/or pharmacotherapy.
20–27SevereImmediate active intervention; referral for specialist care.
GAD-70–4MinimalMonitor; coping strategies.
5–9MildActive monitoring; repeat assessment.
10–14ModerateInitiate counseling or pharmacotherapy evaluation.
15–21SevereImmediate active intervention/specialist consultation.
C-SSRSHigh RiskHighImmediate crisis response, safety plan, psychiatric referral, do not leave patient alone.
Mod RiskModerateUrgent referral, establish safety plan, increase frequency of visits.
Low RiskLowStandard clinical care, provide helpline numbers, safety planning as needed.

Somatic vs. cognitive symptoms: The Indian cultural context

When using these screeners in India, therapists frequently observe that emotional distress is expressed physically (somatization).

In many Indian cultures, admitting to "feeling down, depressed, or hopeless" (PHQ-9 Item 2) carries a heavy social stigma. Instead, clients are more likely to present with physical symptoms such as:

  • Chronic tension headaches
  • Unexplained muscle fatigue or body pain
  • Digestive issues (gas, acidity)
  • Severe sleep disturbances (insomnia or fatigue)

Clinical Tip: If a client scores low on cognitive items but reports significant physical distress, probe further. Validate their somatic experiences first: "I see that you have been struggling with body pain and sleep. Often, when our minds are under a lot of stress, our bodies feel it first. Have you also felt overwhelmed or low?"

Additionally, linguistic variations matter. Standard translations may not capture regional idioms of distress (e.g., "dil ghabrana" in Hindi represents anxiety, but literally translates to "heart fluttering").


Regulatory context: India's Mental Healthcare Act (MHCA) 2017

The MHCA 2017 emphasizes the right to quality mental health care. Under Section 21, mental health services must be run in a non-discriminatory and evidence-guided manner.

Standardized screeners provide the objective data needed to document clinical decisions, justify treatment planning, and maintain compliant records. In the event of legal reviews or disputes, having documented, standardized risk assessments (especially using the C-SSRS for safety) is the strongest protection a clinician can have.


Streamlining screeners in your workflow

Administering and scoring screeners manually during a session consumes valuable therapeutic time.

MyKaya resolves this by separating clinical metrics from narrative notes. The platform allows you to record and track PHQ-9, GAD-7, and C-SSRS scores within a dedicated dashboard in the client’s profile. This keeps your SOAP or DAP notes clean and focused on clinical observation, while ensuring objective outcome measures are permanently recorded, aggregated, and tracked over time.

Learn how MyKaya handles clinical assessments natively.

Frequently Asked Questions

clinical screenersPHQ-9GAD-7C-SSRSIndia